Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CalciMedica Inc CALC

CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses. The Company's technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury. Its lead product candidate is Auxora, a potent and selective intravenous (IV) formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The Company is conducting a Phase 2b trial (called CARPO - NCT04681066) for acute pancreatitis (AP) with systemic inflammatory response syndrome (SIRS), as well as supporting the ongoing Phase 1/2 asparaginase induced pancreatic toxicity (AIPT) study (called CRSPA - NCT04195347).


NDAQ:CALC - Post by User

Post by alphaflighton Apr 22, 2021 10:03am
769 Views
Post# 33044022

Graycliff Exploration Completes Phase 2 Drilling Shakespeare

Graycliff Exploration Completes Phase 2 Drilling Shakespeare
Graycliff Exploration Completes Phase Two Drilling at Shakespeare
 
TORONTO, ON - April 22, 2021 - Graycliff Exploration Limited (the “Company” or “Graycliff”) (CSE: GRAY) (OTCQB: GRYCF) (FSE: GE0) is pleased to announce the completion of the second phase of drilling (“Phase 2 Drilling”, see press release dated March 11, 2021) as part of its 2021 exploration program on the Company’s Shakespeare Gold Project (“Shakespeare”) located on the prolific Canadian Shield near Sudbury, Ontario.
 
Graycliff’s Phase 2 Drilling consisted of 14 core diamond drill holes totalling 2,000 metres and focused on expanding the previously identified mineralization and the new mineralized zone identified in Phase 1 drilling. The mineralized area is located in the vicinity of the Miller Shaft and above the Number 3 adit.
 
“Our technical team worked diligently to complete 14 core holes prior to Spring break-up at site. We have now drilled a total of 3,200 metres in 21 drill holes. Once all the new core is logged and assayed, the combination of the new data and our already disclosed results will give us a much better feel for the mineralized zone. We remain confident that Phase 2 drilling will continue to prove our theories that working in the “shadow” of a historic headframe can be the best place to find a new gold mine” commented Graycliff’s Technical Advisor and Qualified Person, Bruce Durham.
 
Qualified Person
 
Bruce Durham, P.Geo, is a Qualified Person, as that term is defined by Canadian regulatory guidelines under NI 43-101, and has read and approved the technical information contained in this press release. All information other than the results of the two new drill holes are historical in nature and while deemed relevant, should not be relied upon.
 
About Graycliff Exploration Limited
 
Graycliff Exploration is a mineral exploration company focused on its 945 hectares of prospective ground, located roughly 80 kilometres west of Sudbury on the prolific Canadian Shield. The Company's Shakespeare Project consists of one crown patented lease, two crown leases and 40 claims on a property associated with the historic Shakespeare Gold Mine, which operated from 1903 to 1907.
 
For more information, contact investor relations at investors@graycliffexploration.com
 
On Behalf of the Board of Directors,
 
James Macintosh
 
President and CEO

<< Previous
Bullboard Posts
Next >>